Laboratory of Clinical Biochemistry and Metabolism, Department for Pediatrics, Medical Center, University of Freiburg, Freiburg, Germany.
Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
FASEB J. 2018 Oct;32(10):5506-5519. doi: 10.1096/fj.201701141RR. Epub 2018 May 9.
Cobalamin [Cbl (or B)] deficiency causes megaloblastic anemia and a variety of neuropathies. However, homeostatic mechanisms of cyanocobalamin (CNCbl) and other Cbls by vascular endothelial cells are poorly understood. Herein, we describe our investigation into whether cultured bovine aortic endothelial cells (BAECs) perform transcytosis of B, namely, the complex formed between serum transcobalamin and B, designated as holo-transcobalamin (holo-TC). We show that cultured BAECs endocytose [Co]-CNCbl-TC (source material) via the CD320 receptor. The bound Cbl is transported across the cell both via exocytosis in its free form, [Co]-CNCbl, and via transcytosis as [Co]-CNCbl-TC. Transcellular mobilization of Cbl occurred in a bidirectional manner. A portion of the endocytosed [Co]-CNCbl was enzymatically processed by methylmalonic aciduria combined with homocystinuria type C (cblC) with subsequent formation of hydroxocobalamin, methylcobalamin, and adenosylcobalamin, which were also transported across the cell in a bidirectional manner. This demonstrates that transport mechanisms for Cbl in vascular endothelial cells do not discriminate between various β-axial ligands of the vitamin. Competition studies with apoprotein- and holo-TC and holo-intrinsic factor showed that only holo-TC was effective at inhibiting transcellular transport of Cbl. Incubation of BAECs with a blocking antibody against the extracellular domain of the CD320 receptor inhibited uptake and transcytosis by ∼40%. This study reveals that endothelial cells recycle uncommitted intracellular Cbl for downstream usage by other cell types and suggests that the endothelium is self-sufficient for the specific acquisition and subsequent distribution of circulating B via the CD320 receptor. We posit that the endothelial lining of the vasculature is an essential component for the maintenance of serum-tissue homeostasis of B.-Hannibal, L., Bolisetty, K., Axhemi, A., DiBello, P. M., Quadros, E. V., Fedosov, S., Jacobsen, D. W. Transcellular transport of cobalamin in aortic endothelial cells.
钴胺素(Cbl(或 B))缺乏会导致巨幼细胞性贫血和各种神经病变。然而,血管内皮细胞对氰钴胺素(CNCbl)和其他 Cbl 的稳态机制知之甚少。在此,我们描述了我们对培养的牛主动脉内皮细胞(BAEC)是否进行 B 的转胞吞作用的研究,即血清转钴胺素与 B 形成的复合物,命名为全钴胺素(holo-TC)。我们表明,培养的 BAEC 通过 CD320 受体内吞 [Co]-CNCbl-TC(来源材料)。结合的 Cbl 既通过其游离形式 [Co]-CNCbl 的胞吐作用,也通过作为 [Co]-CNCbl-TC 的转胞吞作用穿过细胞。Cbl 的跨细胞移动是双向的。一部分内吞的 [Co]-CNCbl 被甲基丙二酸尿症合并同型半胱氨酸尿症 C 型(cblC)通过随后形成羟钴胺素、甲钴胺素和腺苷钴胺素进行酶促处理,这些物质也以双向方式穿过细胞。这表明血管内皮细胞中的 Cbl 转运机制不会区分维生素的各种β-轴向配体。用载脂蛋白和全钴胺素和全内因子与 apo-TC 和 holo-TC 进行竞争研究表明,只有全钴胺素有效地抑制 Cbl 的跨细胞转运。用针对 CD320 受体细胞外结构域的阻断抗体孵育 BAEC 可抑制摄取和转胞吞作用约 40%。这项研究揭示了内皮细胞为其他细胞类型再循环未承诺的细胞内 Cbl 以供下游使用,并表明内皮细胞通过 CD320 受体对循环 B 的特异性获取和随后分布具有自给自足性。我们假设血管的内皮衬里是维持 B 的血清-组织内稳态的重要组成部分。-Hannibal,L.,Bolisetty,K.,Axhemi,A.,DiBello,P. M.,Quadros,E. V.,Fedosov,S.,Jacobsen,D. W. 主动脉内皮细胞中钴胺素的转胞吞作用。